To access this element change to forms mode OFF
Grant Award View - GA80147
Understanding molecular pathogenesis of therapy related myeloid neoplasm
GA ID:
GA80147
Agency:
Department of Health and Aged Care
Approval Date:
21-Apr-2020
Publish Date:
2-Jun-2020
Category:
Health and Medical Research
Grant Term:
1-Jun-2020 to 31-May-2025
Value (AUD):
$620,205.00
(GST inclusive where applicable)
One-off/Ad hoc:
No
Aggregate Grant Award:
No
PBS Program Name:
DoHAC 18/19 1.1 Health Policy Research and Analysis
Grant Program:
2019_MRFF_Investigator Grants_funding_commencing_June 2020
Grant Activity:
Understanding molecular pathogenesis of therapy related myeloid neoplasm
Purpose:
Some treated cancer patients develop aggressive blood cancers, most probably due to chemotherapy and radiotherapy for their primary cancer. Their survival is less than12 months and they have very limited treatment choices. Hence, understanding of risk factors and mechanisms of treatment-related blood cancers is crucial. We aim to understand the complex interaction between chemotherapy induced damage to bone marrow cells and patient’s genetic factors responsible for treatment related blood cancer.
GO ID:
GO Title:
Investigator Grants: Medical Research Future Fund (MRFF) Priority Round
Internal Reference ID:
MRF1195517
Selection Process:
Targeted or Restricted Competitive
Confidentiality - Contract:
Yes
Confidentiality Reason(s) - Contract:
Privacy Act 1988
Intellectual property
Intellectual property
Confidentiality - Outputs:
Yes
Confidentiality Reason(s) - Outputs:
Intellectual property
Grant Recipient Details
Recipient Name:
University of Adelaide
Recipient ABN:
61 249 878 937
Grant Recipient Location
Suburb:
Adelaide
Town/City:
Adelaide
Postcode:
5000
State/Territory:
SA
Country:
AUSTRALIA
Grant Delivery Location
State/Territory:
SA
Postcode:
Country:
AUSTRALIA